Metabolism and Cardiovascular Diseases / RSU Research week 2025

Metabolism and Cardiovascular Diseases

 

26–27 March, Room 204, RSU, 21 Konsula iela (in-person only)

The session will address emerging therapies and current research in the field of cardiac arrhythmias, sports medicine, cardiomyopathies, interventional cardiology and cardiac surgery. Among the best selected abstracts there will be state-of-the-art lectures presented by local and international faculty.

All RSU RESEARCH WEEK 2025 events are held in English, in a hybrid format – both online and in person, and are free of charge, making it an open platform for every science and innovation enthusiast.

 

Agenda

 

Session I: Metabolism and Cardiovascular Diseases
Chair: Prof. Aivars Lejnieks (Latvia), Prof. Ilze Konrāde (Latvia)
9:00–9:05 Introduction to the Session
Ilze Konrāde, Latvia
9:05–9:25 HMG-CoA Reductase: From Statins Till Energy Metabolism Pathways
Maija Dambrova, Latvia
9:25–9:45 Radiological Techniques for Quantifying Liver Steatosis and Fibrosis
Maija Radziņa, Latvia
9:45–9:55 Alterations in Gastric Microbiota and Biochemical Markers in Autoimmune Atrophic Gastritis and Gastric Neuroendocrine Tumors
Justīne Kaupe, Latvia
9:55–10:05 Predisposing Factors and Treatment Challenges in Diabetic Ketoacidosis: Insights from a Single Centre Data
Inga Orleāne, Latvia
10:05–10:15 Shifted Energy Metabolism Towards Oxidation of Fatty Acids and Lower Physical Activity in Preclinical Model of HFpEF
Reinis Vilšķērsts, Latvia
10:15–10:30 Q&A Session
10:30–11:00 Break

Session II: Sports Medicine / Arrhythmology / Genetics
Chair: Prof. Oskars Kalējs (Latvia), Asst. Prof. Kristīne Jubele (Latvia)
11:00–11:05 Introduction to the Session
Oskars Kalējs, Latvia
11:05–11:25 Athlete’s Heart and Risk of Arrhythmias?
Oskars Kalējs, Latvia
11:25–11:45 Cardiovascular Test Results in Latvian Basketball Veterans
Ketija Apsīte, Latvia
11:45–12:05 Catheter Ablation as a Method of Choice in the Treatment of Atrial Fibrillation
Kristīne Jubele, Latvia
12:05–12:17 Quality of Life in Patients with Atrial Fibrillation Undergoing Pulmonary Vein Isolation: Short Term Follow-up Study
Matīss Linde, Latvia
12:17–12:30 Extrasystole Prevalence Among Master Basketball Players
Ketija Apsīte, Latvia
12:30–13:30 Break

Session III: Cardiomyopathies / Interventional Cardiology
Chair: Assoc. Prof. Andris Skride (Latvia), Assoc. Prof. Ainārs Rudzītis (Latvia)
13:30–13:35 Introduction to the Session
Andris Skride, Latvia
13:35–14:10 Treatable Metabolic Cardiomyopathies
Aleš Linhart, Czechia
14:10–14:20 BPA in Treatment of CTEPH (Latvian PH Registry Data)
Andris Skride, Latvia
14:20–14:30 The Role of Genetic Variants Pathogenesis and Clinical Outcomes of Atrial Fibrillation
Irina Griķe, Latvia
14:30–14:40 The Role of PFO Closure in the Treatment of Migraine
Ainārs Rudzītis, Latvia
14:40–14:50 Chemotherapy-Induced Cardiac 18F-FDG Uptake in Lymphoma Patients: An Early Metabolic Indicator of Cardiotoxicity?
Marika Kalniņa, Latvia
14:50–15:00 Q&A Session
15:00–15:30 Break

Session IV: Contemporary Treatment of Heart Valve Diseases and Beyond
Chair: Prof. Pēteris Stradiņš (Latvia), Assoc. Prof. Mārtiņš Kalējs (Latvia)
15:30–15:35 Introduction to the Session
15:35–15:55 Surgically Implantable Prosthetic Heart Valves in the TAVI Era
Pēteris Stradiņš, Latvia
15:55–16:15 The Transaxillary Concept for Minimally Invasive Cardiac Surgery
Manuel Wilbring, Germany
16:20–16:35 A Progress Report on Transcatheter Heart Valve Therapies in Latvia
Mārtiņš Ērglis, Latvia
16:35–16:50 Aortic Adverse Event Risk Calculator: A Latvian Innovation at Your Fingertips
Ivars Brečs, Latvia
16:50–17:00 Final remarks

 

REGISTRATION FOR THIS CONFERENCE:

KNOWLEDGE FOR USE IN PRACTICE on Medical Health and Research / INTERNATIONAL CONFERENCE ON MEDICAL AND HEALTH RESEARCH / METABOLISM AND CARDIOVASCULAR DISEASES

 

YOU ARE WELCOME TO REGISTER HERE